论文部分内容阅读
当前,癌症研究和治疗的重要进展之一是单克隆抗体(McAb)的发展。那么如今 McAb 的研究处于什么水平呢?作者认为目前已进入第三阶段,并期望是成熟的最后阶段。科学家正逐步认识 McAb 的缺点并设法加以克服。为了弄清抗体在体内中靶机制至少应考虑以下两个方面:(1)是宿主对正常组织和癌组织抗体的调控。抗体注入血流
Currently, one of the important advances in cancer research and treatment is the development of monoclonal antibodies (McAbs). So now what is the level of McAb research? The author believes that it has entered the third phase, and expectations are the final stages of maturity. Scientists are gradually understanding the shortcomings of McAb and trying to overcome it. In order to understand that the target mechanism of antibody in vivo should consider at least the following two aspects: (1) is the host of normal tissue and cancer tissue antibodies. Antibody is injected into the blood stream